Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1963 Sep;17(3):415–445. doi: 10.1038/bjc.1963.58

Relationships of Enzymology to Cancer: A Review*

W R Douglas
PMCID: PMC2071035  PMID: 14062489

Full text

PDF
442

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAMOFF P., CHINCHINIAN H., SAUNDERS J. W., Jr Detection of antigenically distinctive components of mouse melanoma S91. J Natl Cancer Inst. 1959 May;22(5):919–925. doi: 10.1093/jnci/22.5.919. [DOI] [PubMed] [Google Scholar]
  2. ADAMS D. H., BERRY M. E. Some studies on catalase in mouse-liver slices. Biochem J. 1956 Nov;64(3):492–498. doi: 10.1042/bj0640492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ANGELETTI P. U., MOORE B. W., SUNTZEFF V. Similarity of protein and enzyme patterns in different types of malignant tissues. Cancer Res. 1960 Dec;20:1592–1596. [PubMed] [Google Scholar]
  4. ANLYAN A. J., GAMBLE J., HOSTER H. A. Beta-glucuronidase activity of the white blood cells in human leukemias and Hodgkin's disease. Cancer. 1950 Jan;3(1):116–123. doi: 10.1002/1097-0142(1950)3:1<116::aid-cncr2820030114>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  5. ASTRUP T., ALBRECHTSEN O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand J Clin Lab Invest. 1957;9(3):233–243. doi: 10.3109/00365515709079963. [DOI] [PubMed] [Google Scholar]
  6. ASTRUP T., STERNDORFF I. The plasminogen activator in urine and the urinary trypsin inhibitor. Scand J Clin Lab Invest. 1955;7(3):239–245. doi: 10.3109/00365515509134516. [DOI] [PubMed] [Google Scholar]
  7. BAGUENA CANDELA R., FORTEZA BOVER G. [The chloroacetate of naphthol AS-D for the demonstration of the activity of the non-specific esterases in the leukocytes]. Rev Clin Esp. 1961 Sep 15;82:324–327. [PubMed] [Google Scholar]
  8. BAKER R., GOVAN D. The effect of hormonal therapy of prostatic cancer on serum aldolase. Cancer Res. 1953 Feb;13(2):141–146. [PubMed] [Google Scholar]
  9. BENNETT L. L., Jr, SKIPPER H. E., SIMPSON L., WHEELER G. P., WILCOX W. S. Searches for exploitable biochemical differences between normal and cancer cells. V. Cellular conservation of purines. Cancer Res. 1960 Jan;20:62–81. [PubMed] [Google Scholar]
  10. BERENBLUM I. Circumstantial evidence pointing to differences between cancers in terms of etiologic factors. Cancer Res. 1956 Aug;16(7):675–680. [PubMed] [Google Scholar]
  11. BIERMAN H. R., HILL B. R., REINHARDT L., EMORY E. Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas, and the leukemias. Cancer Res. 1957 Aug;17(7):660–667. [PubMed] [Google Scholar]
  12. BLANCHAER M. C., GREEN P. T., MACLEAN J. P., HOLLENBERG M. J. Plasma lactic dehydrogenase and phosphohexose isomerase in leukemia. Blood. 1958 Mar;13(3):245–257. [PubMed] [Google Scholar]
  13. BOCK J. Method for quantitative determination of pepsin in gastric juice. Scand J Clin Lab Invest. 1954;6(3):237–244. [PubMed] [Google Scholar]
  14. BOLIO-CICERO A., AGUIRRE J., PEREZ-TAMAYO R. Malignant peritoneal mesothelioma. Am J Clin Pathol. 1961 Nov;36:417–426. doi: 10.1093/ajcp/36.5.417. [DOI] [PubMed] [Google Scholar]
  15. BONHAM D. G., GIBBS D. F. A new enzyme test for gynaecological cancer. 6-Phosphogluconate dehydrogenase activity in vaginal fluid. Br Med J. 1962 Sep 29;2(5308):823–824. doi: 10.1136/bmj.2.5308.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. BOYLAND E., GASSON J. E., WILLIAMS D. C. Enzyme activity in relation to cancer; the urinary beta-glucuronidase activity of patients suffering from malignant disease. Br J Cancer. 1957 Mar;11(1):120–129. doi: 10.1038/bjc.1957.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. BRAUNSTEIN H., FREIMAN D. G., THOMAS W., Jr, GALL E. A. A histochemical study of the enzymatic activity of lymph nodes. II. Further investigation of normal and hyperplastic lymph nodes. Cancer. 1962 Jan-Feb;15:130–138. doi: 10.1002/1097-0142(196201/02)15:1<130::aid-cncr2820150118>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  18. BRINK N. G., LEWIS U. J., WILLIAMS D. E. Pancreatic elastase: purification, properties, and function. J Biol Chem. 1956 Oct;222(2):705–720. [PubMed] [Google Scholar]
  19. BRUEGGEMANN J., SCHLOSSMANN K., MERKENSCHLAGER M., WALDSCHMIDT M. [On the problem of the presence of serine sulfhydrase]. Biochem Z. 1962;335:392–399. [PubMed] [Google Scholar]
  20. BRUEGGEMANN J., WALDSCHMIDT M. [Serine sulfhydrase from chicken liver. Back reaction and comparison with cysteine desulfhydrase]. Biochem Z. 1962;335:408–422. [PubMed] [Google Scholar]
  21. BRUNS F. H., JACOB W. Studien über Serumenzyme bei Erkrankungen der Leber; die Aktivität der Phosphohexoseiosomerase, Aldolase und alkalischen Phosphatase. Klin Wochenschr. 1954 Nov 15;32(43-44):1041–1044. doi: 10.1007/BF01467137. [DOI] [PubMed] [Google Scholar]
  22. CHAN S. K., McCOY T. A., KIZER D. E. The deletion of tryptophan peroxidase activity during dye carcinogenesis. Cancer Res. 1960 Oct;20:1303–1308. [PubMed] [Google Scholar]
  23. CHRISTENSEN L. K. A method for the determination of uropepsin. Scand J Clin Lab Invest. 1957;9(4):377–379. [PubMed] [Google Scholar]
  24. COHEN S. L., HUSEBY R. A. Inverse changes of serum glucuronidase and esterase of breast cancer patients on estrogen therapy. Proc Soc Exp Biol Med. 1951 Feb;76(2):304–307. doi: 10.3181/00379727-76-18472. [DOI] [PubMed] [Google Scholar]
  25. DE LAMIRANDE G., ALLARD C., CANTERO A. Purine-metabolizing enzymes in normal rat liver and Novikoff hepatoma. Cancer Res. 1958 Sep;18(8 Pt 1):952–958. [PubMed] [Google Scholar]
  26. DODGSON K. S., SPENCER B. Studies on sulphatases. XV. The arylsulphatases of human serum and urine. Biochem J. 1957 Apr;65(4):668–673. doi: 10.1042/bj0650668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. EKMAN B., THUNE S., TRUEDSSON E. Investigation of viscosity and hyaluronidase inhibitors in joint exudate after intra-articular cortisone injections. Scand J Clin Lab Invest. 1953;5(2):175–178. [PubMed] [Google Scholar]
  28. ELSON L. A. Some dynamic aspects of chemical carcinogenesis. Br Med Bull. 1958 May;14(2):161–164. doi: 10.1093/oxfordjournals.bmb.a069661. [DOI] [PubMed] [Google Scholar]
  29. ENDAHL G. L., KOCHAKIAN C. D. Ionic strength of homogenizing medium on glutamic dehydrogenase activity of tissues. Proc Soc Exp Biol Med. 1957 Jan;94(1):192–193. doi: 10.3181/00379727-94-22895. [DOI] [PubMed] [Google Scholar]
  30. FABER V., SCHMITH K. Determination of hyaluronidase inhabitor in serum. Scand J Clin Lab Invest. 1950;2(4):298–302. doi: 10.3109/00365515009056677. [DOI] [PubMed] [Google Scholar]
  31. FISCHER F., SIEBERT G. [Optic test of the determination of alkaline phosphatases in the serum]. Klin Wochenschr. 1961 Feb 15;39:202–204. doi: 10.1007/BF01482954. [DOI] [PubMed] [Google Scholar]
  32. FISHMAN W. H., BAKER J. R., BORGES P. R. Localization of beta-glucuronidase in some human tumors. Cancer. 1959 Mar-Apr;12(2):240–245. doi: 10.1002/1097-0142(195903/04)12:2<240::aid-cncr2820120207>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  33. FISHMAN W. H., DART R. M., BONNER C. D., LEADBETTER W. F., LERNER F., HOMBURGER F. A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate. J Clin Invest. 1953 Oct;32(10):1034–1044. doi: 10.1172/JCI102814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. FISHMAN W. H., LADUE K. T., BORGES P. R. Enzymorphology: a study of free cells. J Histochem Cytochem. 1961 Jul;9:424–429. doi: 10.1177/9.4.424. [DOI] [PubMed] [Google Scholar]
  35. FISHMAN W. H., MITCHELL G. W., Jr Studies on vaginal enzymology. Ann N Y Acad Sci. 1959 Nov 18;83:105–121. doi: 10.1111/j.1749-6632.1960.tb40887.x. [DOI] [PubMed] [Google Scholar]
  36. FISHMAN W. H. Some aspects of cancer enzymology. Bull New Engl Med Cent. 1949 Dec;11(6):235–239. [PubMed] [Google Scholar]
  37. FLETCHER A. P. The measurement of the components of the plasminogen-plasmin system in biological fluids. Biochem J. 1954 Apr;56(4):677–682. doi: 10.1042/bj0560677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. FORSELL O. M., PALVA I. P. Determination of arginase in serum. Scand J Clin Lab Invest. 1961;13:131–133. doi: 10.3109/00365516109137261. [DOI] [PubMed] [Google Scholar]
  39. FORTEZA BOVER G., BAGUENA CANDELA R. [On the cytochemical demonstration of dehydrogenase activity in the leukocytes and thrombocytes of the blood of normal subjects and of patients with chronic myeloid leukemia and polycythemia vera]. Rev Clin Esp. 1961 Dec 15;83:332–337. [PubMed] [Google Scholar]
  40. FREEMAN M. E. Clinical enzyme unitage. Scand J Clin Lab Invest. 1961;13:346–346. [PubMed] [Google Scholar]
  41. FRIEDMAN M. M., BECKER E. Colorimetric determination of blood arginase. Clin Chem. 1955 Apr;1(2):110–116. [PubMed] [Google Scholar]
  42. FUKUI K., NAGATA C., IMAMURA A., TAGASHIRA Y. On the relation between electronic structure and carcinogenic activity of urethan (ethylcarbamate) and related compounds. Gan. 1961 Jun;52:127–134. [PubMed] [Google Scholar]
  43. GAL E. M., ROTH E. Spectrophotometric methods for determination of cholinesterase activity. Clin Chim Acta. 1957 Aug;2(4):316–326. doi: 10.1016/0009-8981(57)90009-8. [DOI] [PubMed] [Google Scholar]
  44. GOLDBARG J. A., RUTENBURG A. M. The colorimetric determination of leucine aminopeptidase in urine and serum of normal subjects and patients with cancer and other diseases. Cancer. 1958 Mar-Apr;11(2):283–291. doi: 10.1002/1097-0142(195803/04)11:2<283::aid-cncr2820110209>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  45. GRACE J. T., Jr, LEHOCZKY A. Tumorhost relationship factors in man. Surgery. 1959 Jul;46(1):238–246. [PubMed] [Google Scholar]
  46. GRAY S. J., RAMSEY C. G., REIFENSTEIN R. W., KRAKAUER L. J. An evaluation of the urinary uropepsin excretion in distinguishing benign from malignant gastric ulcer. Gastroenterology. 1955 Oct;29(4):641-8; discussion, 648-52. [PubMed] [Google Scholar]
  47. GREEN D. E., JARNEFELT J. Enzymes and biological organization. Perspect Biol Med. 1959;2(2):163–184. doi: 10.1353/pbm.1959.0035. [DOI] [PubMed] [Google Scholar]
  48. GREEN J. B. Recent advances in the chemistry of the cerebrospinal fluid. J Nerv Ment Dis. 1958 Oct;127(4):359–373. doi: 10.1097/00005053-195810000-00007. [DOI] [PubMed] [Google Scholar]
  49. GRIBOFF S. I., HERRMANN J. B., SMELIN A., MOSS J. Hypercalcemia secondary to bone metastases from carcinoma of the breast. I. Relationship between serum calcium and alkaline phosphatase values. J Clin Endocrinol Metab. 1954 Apr;14(4):378–388. doi: 10.1210/jcem-14-4-378. [DOI] [PubMed] [Google Scholar]
  50. HARPER H. A. Laboratory aids to diagnosis and therapy (enzymes). Annu Rev Med. 1958;9:461–468. doi: 10.1146/annurev.me.09.020158.002333. [DOI] [PubMed] [Google Scholar]
  51. HEATH R. G., LEACH B. E., BYERS L. W., MARTENS S., FEIGLEY C. A. Pharmacological and biological psychotherapy. Am J Psychiatry. 1958 Feb;114(8):683–689. doi: 10.1176/ajp.114.8.683. [DOI] [PubMed] [Google Scholar]
  52. HEILBRONN E. An electrometric method for the determination of cholinesterase activity. III. Cholinesterase activity in blood spots on filter paper. Scand J Clin Lab Invest. 1953;5(4):308–311. doi: 10.3109/00365515309094204. [DOI] [PubMed] [Google Scholar]
  53. HENLEY K. S., POLLARD H. M. A new method for the determination of glutamic oxalacetic and glutamic pyruvic transaminase in plasma. J Lab Clin Med. 1955 Nov;46(5):785–789. [PubMed] [Google Scholar]
  54. HILL B. R. Further studies of the fractionation of lactic dehydrogenase of blood. Ann N Y Acad Sci. 1958 Oct 13;75(1):304–310. doi: 10.1111/j.1749-6632.1958.tb36878.x. [DOI] [PubMed] [Google Scholar]
  55. HILL B. R., KUFF E. L., HOGEBOOM G. H. Sedimentation behavior of serum lactic dehydrogenase. Proc Soc Exp Biol Med. 1956 Jun;92(2):430–433. doi: 10.3181/00379727-92-22499. [DOI] [PubMed] [Google Scholar]
  56. HODSON A. W., LATNER A. L., RAINE L. Iso-enzymes of alkaline phosphatase. Clin Chim Acta. 1962 Mar;7:255–261. doi: 10.1016/0009-8981(62)90018-9. [DOI] [PubMed] [Google Scholar]
  57. HOFFMANN G. T., ROTTINO A., STERN K. G. Demonstration by the Nadi reaction of cytochrome oxidase activity in cells of the lymphoid and myeloid series obtained from normal individuals and patients suffering from Hodgkin's and other diseases. Blood. 1951 Nov;6(11):1051–1058. [PubMed] [Google Scholar]
  58. HOLMBERG C. G., LAURELL C. B. Oxidase reactions in human plasma caused by coeruloplasmin. Scand J Clin Lab Invest. 1951;3(2):103–107. doi: 10.3109/00365515109060581. [DOI] [PubMed] [Google Scholar]
  59. HSIEH K. M., SUNTZEFF V., COWDRY E. V. Serum lactic dehydrogenase activity as indication of neoplastic growth and regression. Proc Soc Exp Biol Med. 1955 Aug;89(4):627–629. doi: 10.3181/00379727-89-21898. [DOI] [PubMed] [Google Scholar]
  60. HUDSON P. B., TSUBOI K. K., MITTELMAN A. Prostatic cancer. XII. Extremely elevated serum acid phosphatase associated with altered liver function. Am J Med. 1955 Dec;19(6):895–901. doi: 10.1016/0002-9343(55)90157-1. [DOI] [PubMed] [Google Scholar]
  61. JAGT T., LARSEN O. A. Determination of lactic dehydrogenase in ascitic fluid from patients with malignant tumors. Scand J Clin Lab Invest. 1960;12:200–204. doi: 10.3109/00365516009062422. [DOI] [PubMed] [Google Scholar]
  62. JORGENSEN K., SVENDSEN A. Amylose as the substrate in determinations of amylase. Scand J Clin Lab Invest. 1961;13:122–125. doi: 10.3109/00365516109137259. [DOI] [PubMed] [Google Scholar]
  63. JOSEFSSON L., LAGERSTEDT S. Characterization of ribonuclease and determination of its activity. Methods Biochem Anal. 1962;9:39–74. doi: 10.1002/9780470110256.ch2. [DOI] [PubMed] [Google Scholar]
  64. KARMEN A., WROBLEWSKI F., LADUE J. S. Transaminase activity in human blood. J Clin Invest. 1955 Jan;34(1):126–131. doi: 10.1172/JCI103055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. KASDON S. C., HOMBURGER F., YORSHIS E., FISHMAN W. H. Beta-glucuronidase studies in women. VI. Premenopausal vaginal fluid values in relation to invasive cervical cancer. Surg Gynecol Obstet. 1953 Nov;97(5):579–583. [PubMed] [Google Scholar]
  66. KEIDING N. R. Differentiation into three fractions of the serum alkaline phosphatase and the behavior of the fractions in diseases of bone and liver. Scand J Clin Lab Invest. 1959;11:106–112. doi: 10.3109/00365515909060415. [DOI] [PubMed] [Google Scholar]
  67. KERPPOLA W. Observations on the phosphatase content of blood and bone marrow cells in normal and pathologic hemopoiesis. Blood. 1951 May;6(5):454–465. [PubMed] [Google Scholar]
  68. KING E. J., CAMPBELL D. M. International enzyme units. An attempt at international agreement. Clin Chim Acta. 1961 May;6:301–306. doi: 10.1016/0009-8981(61)90054-7. [DOI] [PubMed] [Google Scholar]
  69. KIZER D. E. Relationships between hepatocarcinogenesis and the precancerous loss of 5-hydroxytryptophan decarboxylase activity. Cancer Res. 1962 Feb;22:196–201. [PubMed] [Google Scholar]
  70. KLINKHAMER J. M., EICHEL B. Conservation of multi-enzyme systems through cryogenics. I. Succinoxidase. Nature. 1962 Mar 10;193:944–946. doi: 10.1038/193944a0. [DOI] [PubMed] [Google Scholar]
  71. KOWLESSAR O. D., ALTMAN K. I., HEMPELMANN L. H. Urinary excretion of acid and neutral deoxyribonuclease by rats under normal and post-irradiation conditions. Nature. 1953 Nov 7;172(4384):867–868. doi: 10.1038/172867c0. [DOI] [PubMed] [Google Scholar]
  72. KURNICK N. B. Assay of deoxyribonuclease activity. Methods Biochem Anal. 1962;9:1–38. doi: 10.1002/9780470110256.ch1. [DOI] [PubMed] [Google Scholar]
  73. LADEHOFF A. A., RASMUSSEN J. Fibrinolysis and thromboplastic activity in relation to hemorrhage in transvesical prostatectomy. Scand J Clin Lab Invest. 1961;13:231–244. [PubMed] [Google Scholar]
  74. LAURSEN T. Electrophoresis of serum lactic dehydrogenase on agar gel with fluorimetric determination of the enzyme activity. Scand J Clin Lab Invest. 1962;14:152–156. doi: 10.3109/00365516209079687. [DOI] [PubMed] [Google Scholar]
  75. LIBENSON L., JENA M. Catheptic activity of blood serum in cancer. Cancer. 1957 Sep-Oct;10(5):1004–1007. doi: 10.1002/1097-0142(195709/10)10:5<1004::aid-cncr2820100520>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  76. LUNDH G. Determination of trypsin and chymotrypsin in human intestinal content. Scand J Clin Lab Invest. 1957;9(3):229–232. doi: 10.3109/00365515709079962. [DOI] [PubMed] [Google Scholar]
  77. Lemon H. M., Wisseman C. L., Jr Acid Phosphomonesterase Activity of Human Neoplastic Tissue. Science. 1949 Mar 4;109(2827):233–235. doi: 10.1126/science.109.2827.233. [DOI] [PubMed] [Google Scholar]
  78. MARGULIS R. R., LADD J. E., FAHEY M. F., WALSER H. C. Use of proteolytic enzymes in surgical complications, obstetrics, and gynecology. Am J Obstet Gynecol. 1961 May;81:840–847. doi: 10.1016/s0002-9378(15)33430-x. [DOI] [PubMed] [Google Scholar]
  79. MATHES G., RICHMOND S. G., SPRUNT D. H. The use of L-tartrate in determining prostatic serum acid phosphatase: a report of 514 cases. J Urol. 1956 Jan;75(1):143–150. doi: 10.1016/S0022-5347(17)66789-2. [DOI] [PubMed] [Google Scholar]
  80. MIRAND E. A., BACK N., PRENTICE T. C., AMBRUS J. L., GRACE J. T., Jr Effect of chemotherapeutic agents on Friend virusinduced leukemia in mice. Proc Soc Exp Biol Med. 1961 Nov;108:360–363. doi: 10.3181/00379727-108-26938. [DOI] [PubMed] [Google Scholar]
  81. MOSS D. W. Iso-enzymes of alkaline phosphatase in autolysed and butanol-extracted liver preparations. Nature. 1962 Mar 10;193:981–982. doi: 10.1038/193981a0. [DOI] [PubMed] [Google Scholar]
  82. MYERS W. P. L., BODANSKY O. Comparison of serum phosphohexose isomerase activity and urinary calcium excretion in a patient with metastatic mammary carcinoma. Am J Med. 1957 Nov;23(5):804–809. doi: 10.1016/0002-9343(57)90381-9. [DOI] [PubMed] [Google Scholar]
  83. Markert C. L., Møller F. MULTIPLE FORMS OF ENZYMES: TISSUE, ONTOGENETIC, AND SPECIES SPECIFIC PATTERNS. Proc Natl Acad Sci U S A. 1959 May;45(5):753–763. doi: 10.1073/pnas.45.5.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. NAIRN R. C., RICHMOND H. G., McENTEGART M. G., FOTHERGILL J. E. Immunological differences between normal and malignant cells. Br Med J. 1960 Nov 5;2(5209):1335–1340. doi: 10.1136/bmj.2.5209.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. NARDI G. L., LEES C. W. Serum trypsin; a new diagnostic test for pancreatic disease. N Engl J Med. 1958 Apr 17;258(16):797–798. doi: 10.1056/NEJM195804172581607. [DOI] [PubMed] [Google Scholar]
  86. NIKKILA E. A., PITKANEN E., VUOPIO P., FORSELL O. Erythrocyte enzymes in anemias of different etiology. Ann Med Intern Fenn. 1960;49:187–195. [PubMed] [Google Scholar]
  87. NISSELBAUM J. S., BODANSKY O. Purification and properties of human heart lactic dehydrogenase. J Biol Chem. 1961 Feb;236:323–327. [PubMed] [Google Scholar]
  88. NORBERG B. Serum enzyme studies in some icteric conditions. Clin Chim Acta. 1961 Mar;6:264–271. doi: 10.1016/0009-8981(61)90093-6. [DOI] [PubMed] [Google Scholar]
  89. NYLANDER G. A method of estimating the activity and electrophoretic properties of acid prostate phosphatase. Scand J Clin Lab Invest. 1955;7(3):254–256. doi: 10.3109/00365515509134519. [DOI] [PubMed] [Google Scholar]
  90. PAUL J. The cancer cell in vitro: a review. Cancer Res. 1962 May;22:431–440. [PubMed] [Google Scholar]
  91. PEARSE A. G., PEPLER W. J. A probable peptidase in carcinoid tumours. Nature. 1957 Mar 16;179(4559):589–589. doi: 10.1038/179589a0. [DOI] [PubMed] [Google Scholar]
  92. POPPER H. L., NECHELES H. Pancreas function tests. Med Clin North Am. 1959 Mar;43(2):401–418. doi: 10.1016/s0025-7125(16)34159-1. [DOI] [PubMed] [Google Scholar]
  93. RAPP R. D., BELL E. R. Normal values for serum lactic dehydrogenase. Am J Clin Pathol. 1961 Feb;35:116–117. doi: 10.1093/ajcp/35.2.116. [DOI] [PubMed] [Google Scholar]
  94. RAURAMO L. The significance of tissue beta-glucuronidase content in patients with cancer of the uterus. Scand J Clin Lab Invest. 1959;11:290–293. doi: 10.3109/00365515909060450. [DOI] [PubMed] [Google Scholar]
  95. REICHARD P., SKOLD O., KLEIN G., REVESZ L., MAGNUSSON P. H. Studies on resistance against 5-fluorouracil. I. Enzymes of the uracil pathway during development of resistance. Cancer Res. 1962 Feb;22:235–243. [PubMed] [Google Scholar]
  96. RHODES J. B., WILLIAMS-ASHMAN H. G. Oxidizing enzymes in human seminal plasma. Med Exp Int J Exp Med. 1960;3:123–134. doi: 10.1159/000134936. [DOI] [PubMed] [Google Scholar]
  97. ROBERT J., VAN RYMENANT M., LAGAE F. Enzymes in cancer. III. Triosephosphate isomerase activity of human blood serum in normal individuals and in individuals with various pathological conditions. Cancer. 1961 Nov-Dec;14:1166–1174. doi: 10.1002/1097-0142(196111/12)14:6<1166::aid-cncr2820140605>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  98. ROSE A., WEST M., ZIMMERMAN H. J. Serum enzymes in disease V. Isocitric dehydrogenase, malic dehydrogenase, and glycolytic enzymes in patients with carcinoma of the breast. Cancer. 1961 Jul-Aug;14:726–733. doi: 10.1002/1097-0142(199007/08)14:4<726::aid-cncr2820140409>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  99. ROSE N. R., SHULMAN S., WITEBSKY E. Studies of normal and malignant tissue antigens. Cancer Res. 1956 Oct;16(9):831–841. [PubMed] [Google Scholar]
  100. Riley V., Wroblewski F. Serial Lactic Dehydrogenase Activity in Plasma of Mice with Growing or Regressing Tumors. Science. 1960 Jul 15;132(3420):151–152. doi: 10.1126/science.132.3420.151. [DOI] [PubMed] [Google Scholar]
  101. Roche J. Blood-phosphatases. Biochem J. 1931;25(5):1724–1733. doi: 10.1042/bj0251724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. SABINE J. C. The cholinesterase of erythrocytes in anemias. Blood. 1951 Feb;6(2):151–159. [PubMed] [Google Scholar]
  103. SAFFRAN M., SCARANO E. Mechanism of the incorporation of adenine into adenosine monophosphate. Nature. 1953 Nov 21;172(4386):949–951. doi: 10.1038/172949a0. [DOI] [PubMed] [Google Scholar]
  104. SAYRE F. W., HILL B. R. Fractionation of serum lactic dehydrogenase by salt concentration gradient elution and paper electrophoresis. Proc Soc Exp Biol Med. 1957 Dec;96(3):695–697. doi: 10.3181/00379727-96-23580. [DOI] [PubMed] [Google Scholar]
  105. SCHMITH K., FABER V. The turbidimetric method for determination of hyaluronidase. Scand J Clin Lab Invest. 1950;2(4):292–297. doi: 10.3109/00365515009056676. [DOI] [PubMed] [Google Scholar]
  106. SCHWARTZ M. K., BODANSKY O. Serum adenosine deaminase activity in cancer. Proc Soc Exp Biol Med. 1959 Jul;101(3):560–562. doi: 10.3181/00379727-101-25015. [DOI] [PubMed] [Google Scholar]
  107. STEKOL J. A. Biochemistry in the U.S.S.R. Annu Rev Biochem. 1958;27(3):679–702. doi: 10.1146/annurev.bi.27.070158.003335. [DOI] [PubMed] [Google Scholar]
  108. STERKEL R. L., SPENCER J. A., WOLFSON S. K., Jr, WILLIAMS-ASHMAN H. G. Serum isocitric dehydrogenase activity with particular reference to liver disease. J Lab Clin Med. 1958 Aug;52(2):176–184. [PubMed] [Google Scholar]
  109. STOVNER J. Variation in the cholinesterase-inhibiting effect of succinylcholine. Scand J Clin Lab Invest. 1955;7(3):197–200. doi: 10.3109/00365515509134509. [DOI] [PubMed] [Google Scholar]
  110. STRAUB F. B., STEPHANECK O., ACS G. Plasma adenosine deaminase activity in tumour cases. Biokhimiia. 1957 Jan-Feb;22(1-2):118–121. [PubMed] [Google Scholar]
  111. TAMMELIN L. E. An electrometric method for the determination of cholinesterase activity. I. Apparatus and cholinesterase in human blood. Scand J Clin Lab Invest. 1953;5(3):267–270. doi: 10.3109/00365515309094195. [DOI] [PubMed] [Google Scholar]
  112. THIERS R. E., VALLEE B. L. Analytical considerations in serum enzyme determinations. Ann N Y Acad Sci. 1958 Oct 13;75(1):214–226. doi: 10.1111/j.1749-6632.1958.tb36868.x. [DOI] [PubMed] [Google Scholar]
  113. TILLETT W. S., JOHNSON A. J., McCARTY W. R. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J Clin Invest. 1955 Feb;34(2):169–185. doi: 10.1172/JCI103071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. VETTER K. [The behavior of enzymes in normal and pathological human leukocytes]. Acta Haematol. 1961;26:344–355. doi: 10.1159/000206673. [DOI] [PubMed] [Google Scholar]
  115. WARBURG O. On the origin of cancer cells. Science. 1956 Feb 24;123(3191):309–314. doi: 10.1126/science.123.3191.309. [DOI] [PubMed] [Google Scholar]
  116. WEBER G., CANTERO A. Comparison of carbohydrate metabolism in normal and neoplastic liver enzyme studies. Acta Unio Int Contra Cancrum. 1960;16:1002–1011. [PubMed] [Google Scholar]
  117. WERNER B., MUTT V. The pancreatic response in man to the injection of highly purified secretin and of pancreozymin. Scand J Clin Lab Invest. 1954;6(3):228–236. [PubMed] [Google Scholar]
  118. WINER A. D., SCHWERT G. W. Fluorescence activation spectra of a diphosphopyridine nucleotide dependent dehydrogenase. Science. 1958 Sep 19;128(3325):660–661. doi: 10.1126/science.128.3325.660. [DOI] [PubMed] [Google Scholar]
  119. WOLFSON S. K., SPENCER J. A., STERKEI R. L., WILLIAMS-ASHMAN H. G. Clinical and experimental studies on serum pyridine nucleotide-linked dehydrogenases in liver damage. Ann N Y Acad Sci. 1958 Oct 13;75(1):260–269. doi: 10.1111/j.1749-6632.1958.tb36872.x. [DOI] [PubMed] [Google Scholar]
  120. WROBLEWSKI F., DECKER B., WROBLEWSKI R. The clinical implications of spinal-fluid lactic dehydrogenase activity. N Engl J Med. 1958 Mar 27;258(13):635–639. doi: 10.1056/NEJM195803272581303. [DOI] [PubMed] [Google Scholar]
  121. WROBLEWSKI F. The mechanisms of alteration in lactic dehydrogenase activity of body fluids. Ann N Y Acad Sci. 1958 Oct 13;75(1):322–338. doi: 10.1111/j.1749-6632.1958.tb36880.x. [DOI] [PubMed] [Google Scholar]
  122. WROBLEWSKI F., WROBLEWSKI R. The clinical significance of lactic dehydrogenase activity of serous effusions. Ann Intern Med. 1958 Apr;48(4):813–822. doi: 10.7326/0003-4819-48-4-813. [DOI] [PubMed] [Google Scholar]
  123. WYNDER E. L. Some thoughts on the epidemiology of cancer. Cancer Res. 1961 Aug;21:858–861. [PubMed] [Google Scholar]
  124. XEFTERIS E., MITUS W. J., MEDNICOFF I. B., DAMESHEK W. Leukocytic alkaline phosphatase in busulfan-induced remissions of chronic granulocytic leukemia. Blood. 1961 Aug;18:202–206. [PubMed] [Google Scholar]
  125. YOUNG I. I. Serum 5-nucleotidase; characterization and evaluation in disease states. Ann N Y Acad Sci. 1958 Oct 13;75(1):357–362. doi: 10.1111/j.1749-6632.1958.tb36883.x. [DOI] [PubMed] [Google Scholar]
  126. ZUCKER M. B., BORELLI J. A survey of some platelet enzymes and functions; the platelets as the source of normal serum acid glycerophosphatase. Ann N Y Acad Sci. 1958 Oct 13;75(1):203–213. doi: 10.1111/j.1749-6632.1958.tb36867.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES